Executive Summary
A single massive $374M HHS/CDC contract with Plowshare Group (Publicis Groupe subsidiary) nears its March 30, 2026 end, with $275M already outlayed providing stable T&M revenue amid full obligation drawdown. Unexercised options worth $124M offer upside, but funding renewal post-2026 remains uncertain. Investors in Publicis Groupe gain confirmed government-backed cash flow visibility into Q1 2026.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior All HHS Contracts digest from March 29, 2026.
Investment Signals (1)
- Publicis Groupe locks in $275M+ CDC revenue stream (HIGH)▲
$373.9M obligated (potential $497.8M with options) T&M contract for National Tobacco Education Campaign delivers multi-year stability, with 74% ($275.5M) already outlayed.
Risk Flags (2)
- Execution [MEDIUM RISK]▼
T&M structure exposes to government audits on hours/rates; only 74% of obligation outlayed with $98M remaining uncertain.
- Regulatory [HIGH RISK]▼
Contract ends March 30, 2026; potential funding cuts or non-renewal in CDC tobacco programs.
Opportunities (2)
- ◆
$123.9M unexercised options could boost revenue if activated before 2026 end.
- ◆
Follow-on CDC tobacco campaign work post-2026 leveraging incumbent status.
Sector Themes (1)
- ◆
Single $374M CDC tobacco campaign contract highlights concentrated federal outlays to ad agencies through 2026.
Watch List (2)
- 👁
{"entity"=>"Publicis Groupe S.A.", "reason"=>"Reliance on $374M HHS contract for stable revenue; 74% drawn signals execution but end-date looms.", "trigger"=>"Q4 2025 earnings mention of CDC outlays/options"}
- 👁
{"entity"=>"CDC National Tobacco Education Campaign", "reason"=>"Contract concentration risk; potential for renewal or expansion.", "trigger"=>"FY2027 HHS budget allocation or new awards"}
Get daily alerts with 1 investment signals, 2 risk alerts, 2 opportunities and full AI analysis of all 1 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: All HHS Contracts
🇺🇸 More from United States
View all →May 27, 2026
US Pre-Market SEC Filings Roundup — May 27, 2026
US Pre-Market SEC Filings Roundup
May 27, 2026
S&P 500 Technology Sector SEC Filings — May 27, 2026
S&P 500 Technology Sector SEC Filings
May 27, 2026
Orphan Drug Approvals — May 27, 2026
Orphan Drug Approvals
May 27, 2026
Big Pharma Approvals — May 27, 2026
Big Pharma Approvals